Diagnostic Imaging Drug Development Expertise

From lab to market
We provide full-service Imaging Diagnostics Clinical Development, from pre-clinical to IND and NDA submission and Medical Affairs.

We have developed current market leaders
We have led 7 imaging new drug approvals globally: MRI, CT, and radiopharmaceuticals.

Literature-based approvals
Utilizing only existing literature reviews, we have gained 5 new indications for imaging drugs without performing additional clinical trials.

Over 40 years of experience
Between our two RadMD principals, there are over 40 years of contrast agent development experience.

Imaging management solutions
Our full-service imaging management solutions provide a comprehensive set of services to support pharmaceutical, medical device and AI companies with their clinical trials.

Our reader group
We are the global leader in providing consultants to perform imaging BICR (blinded independent central reviews)

Diagnostic Imaging Drug Development Expertise
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
We have 12 years of experience in comprehensive sourcing and management of our readers for over 600 trials.
Latest News
RadMD attend Clinical Operations in Oncology Conference
Last week, the RadMD team had the incredible opportunity to be part of the Clinical Operations in Oncology conference in Boston. It was an immersive experience where we connected with esteemed…
RadMD new headquarters
RadMD, celebrated a significant milestone as we commemorated the opening of our new office in Conshohocken, PA last week. The achievement marks a remarkable journey that began 17 years ago in a barn…
The American Society of Clinical Oncology (ASCO) Conference
The American Society of Clinical Oncology (ASCO) Conference took place from June 2nd to June 6th, 2023, and RadMD was among the attendees. During the conference, RadMD provided an opportunity for…